According to the New York Times, a judge granted Mann an injunction in April that blocked Boston Scientific from firing him or chief executive Jeffrey Greiner from daily management at the company. Boston Scientific willÂ give formerÂ Advanced Bionics shareholders $1.15 billion to buy the company'sÂ pain management division. It will also sellÂ back the company's auditory business and drug pump development program to an Advanced Bionics investment group for $150 million. The deal should save Boston Scientific $500 million in payments and possibly $2.1 billion that could have come up in the future. The transaction is expected to be completed in January 2008. UPDATE: The sale has been completed.